These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30365132)
1. Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line. Zhang C; He LJ; Ye HZ; Liu DF; Zhu YB; Miao DD; Zhang SP; Chen YY; Jia YW; Shen J; Liu XP Mol Med Rep; 2018 Dec; 18(6):5409-5416. PubMed ID: 30365132 [TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell. Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143 [TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R. Xiao H; Xiao Q; Zhang K; Zuo X; Shrestha UK Ann Hematol; 2010 Apr; 89(4):399-404. PubMed ID: 19756599 [TBL] [Abstract][Full Text] [Related]
4. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells. Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654 [TBL] [Abstract][Full Text] [Related]
5. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer. Yuan ZT; Shi XJ; Yuan YX; Qiu YY; Zou Y; Liu C; Yu H; He X; Xu K; Yin PH Oncotarget; 2017 Jul; 8(29):48012-48026. PubMed ID: 28624793 [TBL] [Abstract][Full Text] [Related]
6. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells. Zheng ZH; You HY; Feng YJ; Zhang ZT Mol Cell Biochem; 2021 Jul; 476(7):2575-2585. PubMed ID: 32757174 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Fan H; Zhu JH; Yao XQ Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171 [TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B reverses multidrug resistance in HCT‑8/VCR human colorectal cancer cells by increasing ROS levels. Guo P; Wang S; Liang W; Wang W; Wang H; Zhao M; Liu X Mol Med Rep; 2017 Feb; 15(2):724-730. PubMed ID: 28000873 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of reversal of multidrug resistance by curcumin in human colorectal cancer cell line HCT-8/5-FU. Fan YX; Abulimiti P; Zhang HL; Zhou YK; Zhu L Genet Mol Res; 2017 Jun; 16(2):. PubMed ID: 28671249 [TBL] [Abstract][Full Text] [Related]
10. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233 [TBL] [Abstract][Full Text] [Related]
11. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells. Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756 [TBL] [Abstract][Full Text] [Related]
12. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Tang XQ; Bi H; Feng JQ; Cao JG Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression. Shen K; Cui D; Sun L; Lu Y; Han M; Liu J J Cell Biochem; 2012 Jun; 113(6):2086-97. PubMed ID: 22275271 [TBL] [Abstract][Full Text] [Related]
14. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro. Yang S; Liu J; Chen Y; Jiang J Biomed Pharmacother; 2012 Apr; 66(3):187-94. PubMed ID: 22440896 [TBL] [Abstract][Full Text] [Related]
15. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
16. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway. Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells. Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516 [TBL] [Abstract][Full Text] [Related]
18. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis. Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of curcumin mimics with multidrug resistance reversal activities. Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490 [TBL] [Abstract][Full Text] [Related]
20. Application of curcumin and its derivatives in tumor multidrug resistance. Xu T; Guo P; He Y; Pi C; Wang Y; Feng X; Hou Y; Jiang Q; Zhao L; Wei Y Phytother Res; 2020 Oct; 34(10):2438-2458. PubMed ID: 32255545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]